63 results
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified as a financial
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Nov 23
Condensed Consolidated Interim Financial Statements
1:05pm
The obligation to pay royalties of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently … were classified as liability. Management was required to make estimates to determine the fair value of the components of the preference share
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
of $16 million USD is classified as a financial liability and measured initially at its fair value and subsequently at amortized cost. Management … redemption RepliCel preference shares were classified as liability. Management was required to make estimates to determine the fair value of the components
6-K
EX-99.1
REPCF
Replicel Life Sciences Inc.
24 Oct 23
Condensed Consolidated Interim Financial Statements
11:10am
at an agreed price at a future date, which is a derivative liability accounted for at FVTPL.
The obligation to pay royalties of $16 million USD is classified
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
for at FVTPL.
- 12 -
The obligation to pay royalties of $16 million USD is classified as a financial liability and measured initially at its fair value … to required redemption RepliCel preference shares were classified as liability. Management was required to make estimates to determine the fair value
6-K
EX-99.1
3i1z274csssb
30 May 23
Condensed Consolidated Interim Financial Statements
5:40pm
6-K
EX-99.2
u1060 jyenf71bh
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
6-K
EX-99.1
wsfbx
29 Nov 22
Condensed Consolidated Interim Financial Statements
6:44pm
20-F/A
9a4fwpc
12 Sep 22
Annual report (foreign) (amended)
6:17pm
6-K
EX-99.1
9v3rj
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.2
p49 1cfocpf
6 Sep 22
Condensed Consolidated Interim Financial Statements
12:42pm
6-K
EX-99.4
nvgxd 40h
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.3
tgsc01
7 Jul 22
RepliCel Provides Update on Private Placement
3:36pm
6-K
EX-99.2
qim8oeka 6zql
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
xj5iscz6 x954
30 Nov 21
Condensed Consolidated Interim Financial Statements
1:50pm
6-K
EX-99.1
d4set5 0wtd3atfq
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
0w2yxaa1x0ov2yj
31 Aug 21
Condensed Consolidated Interim Financial Statements
1:45pm
6-K
EX-99.2
8a87z
1 Jun 21
Condensed Consolidated Interim Financial Statements
3:57pm